-
Je něco špatně v tomto záznamu ?
Adjuvant Stereotactic Radiosurgery With or Without Postresection Fractionated Radiation Therapy for the Management of Clival Chordomas in Adults: An International Multicenter Case Series
O. Bin-Alamer, S. Pikis, G. Mantziaris, A. Abdulbaki, AN. Mallela, VM. Lu, S. Peker, Y. Samanci, AM. Nabeel, WA. Reda, SR. Tawadros, AMN. El-Shehaby, K. Abdelkarim, RM. Emad Eldin, D. Sheehan, K. Sheehan, R. Liscak, T. Chytka, M. Tripathi, R....
Jazyk angličtina Země Spojené státy americké
Typ dokumentu multicentrická studie, časopisecké články
- MeSH
- chordom * radioterapie chirurgie MeSH
- dospělí MeSH
- lidé MeSH
- nádory hlavy a krku * MeSH
- následné studie MeSH
- radiochirurgie * škodlivé účinky MeSH
- retrospektivní studie MeSH
- výsledek terapie MeSH
- Check Tag
- dospělí MeSH
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- multicentrická studie MeSH
BACKGROUND: Clival chordomas are challenging because of their proximity to critical neurovascular structures. Stereotactic radiosurgery (SRS) has been proven effective with minimal adverse effects. OBJECTIVE: To compare the outcomes of histologically confirmed primary clival chordomas in adults who underwent SRS alone (SRS group) vs SRS after fractionated radiotherapy (FRT+SRS group). METHODS: We collected patient data from 10 institutions affiliated with the International Radiosurgery Research Foundation. We evaluated overall survival, tumor control, and freedom from additional treatment (FFAT). RESULTS: Fifty-seven (77%) patients were included in the SRS group and 17 (23%) in the FRT+SRS group. The median radiological follow-up was 48 months (IQR, 24-85) in the SRS group and 36 months (IQR, 25-41) in the FRT+SRS group. During the follow-up, 8 SRS and 2 FRT+SRS patients died ( P = .80). The groups had comparable 10-year overall survival (SRS: 76% vs FRT+SRS: 80%; logrank test, P = .75) and tumor control rates (SRS: 34% vs FRT+SRS: 45%; logrank test, P = .29). The SRS group had a superior 10-year FFAT rate (40%) compared with FRT+SRS (23%; logrank test, P = .02). This finding persisted in the multivariate analysis of the Cox proportional hazards illustrating a 2.40-fold increase in the relative risk of requiring additional treatment among the FRT+SRS group ( P = .04). CONCLUSION: Adjuvant FRT with subsequent boost SRS did not provide superior overall survival or tumor control compared with patients who underwent adjuvant SRS alone. Further studies are required to refine management guidelines among adults with clival chordomas.
Department of Neurological Surgery University of Miami School of Medicine Miami Florida USA
Department of Neurological Surgery University of Pittsburgh Pittsburgh Pennsylvania USA
Department of Neurological Surgery University of Virginia Charlottesville Virginia USA
Department of Neurosurgery Ain Shams University Cairo Egypt
Department of Neurosurgery Benha University Benha Egypt
Department of Neurosurgery Cleveland Clinic Cleveland Ohio USA
Department of Neurosurgery Hannover Medical School Hannover Germany
Department of Neurosurgery Koc University School of Medicine Istanbul Turkey
Department of Neurosurgery New York University Langone New York New York USA
Department of Radiation and Stereotactic Neurosurgery Na Homolce Hospital Prague Czech Republic
Department of Radiation Oncology National Cancer Institute Cairo University Cairo Egypt
Department of Radiation Oncology New York University Langone New York New York USA
Department of Radiation Oncology University of Virginia Charlottesville Virginia USA
Department of Radiology Dominican Gamma Knife Center and CEDIMAT Santo Domingo Dominican Republic
Gamma Knife Center Cairo Nasser Institute Hospital Cairo Egypt
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23016174
- 003
- CZ-PrNML
- 005
- 20231026110250.0
- 007
- ta
- 008
- 231013s2023 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1227/neu.0000000000002488 $2 doi
- 035 __
- $a (PubMed)37052386
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Bin-Alamer, Othman $u Department of Neurological Surgery, University of Pittsburgh, Pittsburgh , Pennsylvania , USA $1 https://orcid.org/0000000193654115
- 245 10
- $a Adjuvant Stereotactic Radiosurgery With or Without Postresection Fractionated Radiation Therapy for the Management of Clival Chordomas in Adults: An International Multicenter Case Series / $c O. Bin-Alamer, S. Pikis, G. Mantziaris, A. Abdulbaki, AN. Mallela, VM. Lu, S. Peker, Y. Samanci, AM. Nabeel, WA. Reda, SR. Tawadros, AMN. El-Shehaby, K. Abdelkarim, RM. Emad Eldin, D. Sheehan, K. Sheehan, R. Liscak, T. Chytka, M. Tripathi, R. Madan, H. Speckter, W. Hernández, GH. Barnett, YS. Hori, N. Dabhi, S. Aldakhil, D. Mathieu, D. Kondziolka, K. Bernstein, Z. Wei, A. Niranjan, CR. Kersh, LD. Lunsford, JP. Sheehan, H. Abou-Al-Shaar
- 520 9_
- $a BACKGROUND: Clival chordomas are challenging because of their proximity to critical neurovascular structures. Stereotactic radiosurgery (SRS) has been proven effective with minimal adverse effects. OBJECTIVE: To compare the outcomes of histologically confirmed primary clival chordomas in adults who underwent SRS alone (SRS group) vs SRS after fractionated radiotherapy (FRT+SRS group). METHODS: We collected patient data from 10 institutions affiliated with the International Radiosurgery Research Foundation. We evaluated overall survival, tumor control, and freedom from additional treatment (FFAT). RESULTS: Fifty-seven (77%) patients were included in the SRS group and 17 (23%) in the FRT+SRS group. The median radiological follow-up was 48 months (IQR, 24-85) in the SRS group and 36 months (IQR, 25-41) in the FRT+SRS group. During the follow-up, 8 SRS and 2 FRT+SRS patients died ( P = .80). The groups had comparable 10-year overall survival (SRS: 76% vs FRT+SRS: 80%; logrank test, P = .75) and tumor control rates (SRS: 34% vs FRT+SRS: 45%; logrank test, P = .29). The SRS group had a superior 10-year FFAT rate (40%) compared with FRT+SRS (23%; logrank test, P = .02). This finding persisted in the multivariate analysis of the Cox proportional hazards illustrating a 2.40-fold increase in the relative risk of requiring additional treatment among the FRT+SRS group ( P = .04). CONCLUSION: Adjuvant FRT with subsequent boost SRS did not provide superior overall survival or tumor control compared with patients who underwent adjuvant SRS alone. Further studies are required to refine management guidelines among adults with clival chordomas.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a radiochirurgie $x škodlivé účinky $7 D016634
- 650 _2
- $a výsledek terapie $7 D016896
- 650 12
- $a chordom $x radioterapie $x chirurgie $7 D002817
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 12
- $a nádory hlavy a krku $7 D006258
- 650 _2
- $a následné studie $7 D005500
- 655 _2
- $a multicentrická studie $7 D016448
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Pikis, Stylianos $u Department of Neurological Surgery, University of Virginia, Charlottesville , Virginia , USA
- 700 1_
- $a Mantziaris, Georgios $u Department of Neurological Surgery, University of Virginia, Charlottesville , Virginia , USA
- 700 1_
- $a Abdulbaki, Arif $u Department of Neurosurgery, Hannover Medical School, Hannover , Germany
- 700 1_
- $a Mallela, Arka N $u Department of Neurological Surgery, University of Pittsburgh, Pittsburgh , Pennsylvania , USA
- 700 1_
- $a Lu, Victor M $u Department of Neurological Surgery, University of Miami School of Medicine, Miami , Florida , USA
- 700 1_
- $a Peker, Selcuk $u Department of Neurosurgery, Koc University School of Medicine, Istanbul , Turkey
- 700 1_
- $a Samanci, Yavuz $u Department of Neurosurgery, Koc University School of Medicine, Istanbul , Turkey
- 700 1_
- $a Nabeel, Ahmed M $u Gamma Knife Center Cairo, Nasser Institute Hospital, Cairo , Egypt $u Department of Neurosurgery, Benha University, Benha , Egypt
- 700 1_
- $a Reda, Wael A $u Gamma Knife Center Cairo, Nasser Institute Hospital, Cairo , Egypt $u Department of Neurosurgery, Ain Shams University, Cairo , Egypt
- 700 1_
- $a Tawadros, Sameh R $u Gamma Knife Center Cairo, Nasser Institute Hospital, Cairo , Egypt $u Department of Neurosurgery, Ain Shams University, Cairo , Egypt
- 700 1_
- $a El-Shehaby, Amr M N $u Gamma Knife Center Cairo, Nasser Institute Hospital, Cairo , Egypt $u Department of Neurosurgery, Ain Shams University, Cairo , Egypt
- 700 1_
- $a Abdelkarim, Khaled $u Gamma Knife Center Cairo, Nasser Institute Hospital, Cairo , Egypt $u Department of Neurosurgery, Ain Shams University, Cairo , Egypt
- 700 1_
- $a Emad Eldin, Reem M $u Gamma Knife Center Cairo, Nasser Institute Hospital, Cairo , Egypt $u Department of Radiation Oncology, National Cancer Institute, Cairo University, Cairo , Egypt
- 700 1_
- $a Sheehan, Darrah $u Department of Neurological Surgery, University of Virginia, Charlottesville , Virginia , USA
- 700 1_
- $a Sheehan, Kimball $u Department of Neurological Surgery, University of Virginia, Charlottesville , Virginia , USA
- 700 1_
- $a Liscak, Roman $u Department of Radiation and Stereotactic Neurosurgery, Na Homolce Hospital, Prague , Czech Republic
- 700 1_
- $a Chytka, Tomas $u Department of Radiation and Stereotactic Neurosurgery, Na Homolce Hospital, Prague , Czech Republic
- 700 1_
- $a Tripathi, Manjul $u Department of Neurosurgery and Radiotherapy, Postgraduate Institute of Medical Education and Research, Chandigarh , India
- 700 1_
- $a Madan, Renu $u Department of Neurosurgery and Radiotherapy, Postgraduate Institute of Medical Education and Research, Chandigarh , India
- 700 1_
- $a Speckter, Herwin $u Department of Radiology, Dominican Gamma Knife Center and CEDIMAT, Santo Domingo , Dominican Republic
- 700 1_
- $a Hernández, Wenceslao $u Department of Radiology, Dominican Gamma Knife Center and CEDIMAT, Santo Domingo , Dominican Republic
- 700 1_
- $a Barnett, Gene H $u Department of Neurosurgery, Cleveland Clinic, Cleveland , Ohio , USA
- 700 1_
- $a Hori, Yusuke S $u Department of Neurosurgery, Cleveland Clinic, Cleveland , Ohio , USA
- 700 1_
- $a Dabhi, Nisha $u Department of Neurological Surgery, University of Virginia, Charlottesville , Virginia , USA
- 700 1_
- $a Aldakhil, Salman $u Department of Neurosurgery, Université de Sherbrooke, Centre de recherche du CHUS, Sherbrooke , Quebec , Canada
- 700 1_
- $a Mathieu, David $u Department of Neurosurgery, Université de Sherbrooke, Centre de recherche du CHUS, Sherbrooke , Quebec , Canada
- 700 1_
- $a Kondziolka, Douglas $u Department of Neurosurgery, New York University Langone, New York , New York , USA
- 700 1_
- $a Bernstein, Kenneth $u Department of Radiation Oncology, New York University Langone, New York , New York , USA
- 700 1_
- $a Wei, Zhishuo $u Department of Neurological Surgery, University of Pittsburgh, Pittsburgh , Pennsylvania , USA
- 700 1_
- $a Niranjan, Ajay $u Department of Neurological Surgery, University of Pittsburgh, Pittsburgh , Pennsylvania , USA
- 700 1_
- $a Kersh, Charles R $u Department of Radiation Oncology, University of Virginia, Charlottesville , Virginia , USA
- 700 1_
- $a Lunsford, L Dade $u Department of Neurological Surgery, University of Pittsburgh, Pittsburgh , Pennsylvania , USA
- 700 1_
- $a Sheehan, Jason P $u Department of Neurological Surgery, University of Virginia, Charlottesville , Virginia , USA
- 700 1_
- $a Abou-Al-Shaar, Hussam $u Department of Neurological Surgery, University of Pittsburgh, Pittsburgh , Pennsylvania , USA $1 https://orcid.org/0000000291205970
- 773 0_
- $w MED00003511 $t Neurosurgery $x 1524-4040 $g Roč. 93, č. 4 (2023), s. 892-900
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37052386 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20231013 $b ABA008
- 991 __
- $a 20231026110244 $b ABA008
- 999 __
- $a ok $b bmc $g 1999980 $s 1202536
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 93 $c 4 $d 892-900 $e 20230413 $i 1524-4040 $m Neurosurgery $n Neurosurgery $x MED00003511
- LZP __
- $a Pubmed-20231013